Richard J. Cote, M.D.
- Fax: 305-243-5929
- American Board of Pathology-Anatomic
- Professor and Joseph R. Coulter Jr. Chair, Department of Pathology
Richard J. Cote, M.D., FRCPath, FCAP is the Joseph R. Coulter Jr. Chair of the Department of Pathology, and Director of the Dr. John T. Macdonald Foundation Biomedical Nanotechnology Institute at the University of Miami Miller School of Medicine. He is a board certified Pathologist, who has served over 20 years in senior academic, consultative, and director/clinical roles with leading universities, hospitals and healthcare enterprises primarily in the area of cancer care.
Dr. Cote obtained degrees in chemistry and biology at the University of California at Irvine, and received his medical degree from the University of Chicago - Pritzker School of Medicine. He completed his residency at New York Hospital - Cornell University Medical College. His training included a clinical fellowship in pathology at Memorial Sloan-Kettering Cancer Center, a research fellowship in Human Tumor Immunology at Memorial Sloan-Kettering Cancer Center and a fellowship in Molecular Pathology at New York University School of Medicine. Prior to joining the University of Miami in 2009, he was Professor, Department of Pathology; Professor, Department of Urology; Director, Genitourinary Cancer Program; Director, Laboratory of Immunology and Molecular Pathology; and Director of the USC Biomedical Nanoscience Initiative at the University of Southern California Keck School of Medicine/Norris Cancer Center in Los Angeles.
Dr. Cote’s research is focused on the elucidation of cellular and molecular pathways of tumor progression and response to therapy. He has special interests in micrometastases detection and characterization and in the pathology of breast and genitourinary tumors. His laboratory is also focused on technology development, where Dr. Cote and his colleagues have developed immunohistochemical and molecular methods, such as antigen retrieval. Most recently, Dr. Cote and his colleagues at the University of Southern California, Caltech and UC Berkeley have developed nanoscale technologies for cancer diagnostic applications, including bionanosensors for the detection of serum tumor markers, and technologies for the capture and characterization of circulating tumor cells. As a result of these efforts, he established the Biomedical Nanoscience Program at USC and the Dr. John T. Macdonald Biomedical Nanotechnology Institute at the University of Miami (which recently received a $7.5 million naming gift for the Dr. John T. Macdonald Foundation), for the development of novel diagnostic platforms and targeted therapeutics. He is the recipient of over $43 million in peer reviewed grant support, and holds numerous patents for cancer related and nanoscale technologies. He has led three of the largest clinical trials in breast, lung and bladder cancer, which were based on discoveries from his research. Dr. Cote is the author of over 300 publications, and participates on numerous scientific advisory boards for both academic and industry related institutions. Since his arrival 5 years ago as Chair of Pathology at the University of Miami, Dr. Cote has overseen an increase in Department revenues of over 300%, and an improvement in NIH funding ranking of nearly 60 positions. He is a frequent lecturer and is the co-author of the standard textbooks “Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist” (now in its third edition), and “Modern Surgical Pathology” (now in its second edition). He also serves as a member and advisor to a large number of national and international study groups, cancer programs and societies, including the National Cancer Institute. He is the founder of several technology based companies, including Impath, Inc., Clarient, Filtini and Sensitini. He is listed in “US News and World report Top 1% of Doctors”, “Best Doctors in America”, “America’s Top Doctors”, and “South Florida Super Doctors”. He was awarded the 2013 Distinguished Alumnus of the Year by the School of Physical Sciences at the University of California, Irvine, was elected to the Association of American Physicians in 2010, is a member of Phi Beta Kappa and the Alpha Omega Alpha Medical Honor Society, and awarded the Bio-Medical Health Care Heroes Award on May 19, 2015.